Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer

Soluble programmed death-1 ligand (sPD-L1) in the serum of non-small cell lung cancer (NSCLC) patients is a crucial factor in disease prognosis and an indicator for immunotherapy response. This study aimed to evaluate changes in sPD-L1 levels in advanced NSCLC patients. Between May 2018 and October...

Full description

Saved in:
Bibliographic Details
Main Authors: Ta Thang Ba, Pham Nhung Thi Kim, Nguyen Dung Tien, Tran Tien Viet, Tran Cuong Tan, Cong Luong Thuc, Vu Hoan Ngoc, Le Hien Thi Dieu, Dao Bang Ngoc
Format: Article
Language:English
Published: Sciendo 2024-11-01
Series:Forum of Clinical Oncology
Subjects:
Online Access:https://doi.org/10.2478/fco-2023-0036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225053427728384
author Ta Thang Ba
Pham Nhung Thi Kim
Nguyen Dung Tien
Tran Tien Viet
Tran Cuong Tan
Cong Luong Thuc
Vu Hoan Ngoc
Le Hien Thi Dieu
Dao Bang Ngoc
author_facet Ta Thang Ba
Pham Nhung Thi Kim
Nguyen Dung Tien
Tran Tien Viet
Tran Cuong Tan
Cong Luong Thuc
Vu Hoan Ngoc
Le Hien Thi Dieu
Dao Bang Ngoc
author_sort Ta Thang Ba
collection DOAJ
description Soluble programmed death-1 ligand (sPD-L1) in the serum of non-small cell lung cancer (NSCLC) patients is a crucial factor in disease prognosis and an indicator for immunotherapy response. This study aimed to evaluate changes in sPD-L1 levels in advanced NSCLC patients. Between May 2018 and October 2022, 80 patients with advanced-stage NSCLC and 30 healthy volunteers participated in a prospective study.
format Article
id doaj-art-bff40781b6fa47539dbda48698f9bde5
institution Kabale University
issn 1792-362X
language English
publishDate 2024-11-01
publisher Sciendo
record_format Article
series Forum of Clinical Oncology
spelling doaj-art-bff40781b6fa47539dbda48698f9bde52025-08-25T06:11:53ZengSciendoForum of Clinical Oncology1792-362X2024-11-01151364410.2478/fco-2023-0036Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancerTa Thang Ba0Pham Nhung Thi Kim1Nguyen Dung Tien2Tran Tien Viet3Tran Cuong Tan4Cong Luong Thuc5Vu Hoan Ngoc6Le Hien Thi Dieu7Dao Bang Ngoc8Respiratory Center, Military Hospital 103, Vietnam Military Medical UniversityRespiratory Center, Military Hospital 103, Vietnam Military Medical UniversityRespiratory Center, Military Hospital 103, Vietnam Military Medical UniversityDepartment of Infectious Diseases, Military Hospital 103, Vietnam Military Medical UniversityRespiratory Center, Military Hospital 103, Vietnam Military Medical UniversityCardiovascular Center, Military Hospital 103, Vietnam Medical Military UniversityDepartment of Military Epidemiology, Vietnam Medical Military UniversityRespiratory Department, Hai Phong University of Medicine and PharmacyRespiratory Center, Military Hospital 103, Vietnam Military Medical UniversitySoluble programmed death-1 ligand (sPD-L1) in the serum of non-small cell lung cancer (NSCLC) patients is a crucial factor in disease prognosis and an indicator for immunotherapy response. This study aimed to evaluate changes in sPD-L1 levels in advanced NSCLC patients. Between May 2018 and October 2022, 80 patients with advanced-stage NSCLC and 30 healthy volunteers participated in a prospective study.https://doi.org/10.2478/fco-2023-0036soluble pd-l1 (spd-l1)membrane pd-l1 (mpd-l1)non-small cell lung cancer (nsclc)
spellingShingle Ta Thang Ba
Pham Nhung Thi Kim
Nguyen Dung Tien
Tran Tien Viet
Tran Cuong Tan
Cong Luong Thuc
Vu Hoan Ngoc
Le Hien Thi Dieu
Dao Bang Ngoc
Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
Forum of Clinical Oncology
soluble pd-l1 (spd-l1)
membrane pd-l1 (mpd-l1)
non-small cell lung cancer (nsclc)
title Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
title_full Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
title_fullStr Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
title_full_unstemmed Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
title_short Changes in soluble PD-L1 levels in patients with advanced non-small cell lung cancer
title_sort changes in soluble pd l1 levels in patients with advanced non small cell lung cancer
topic soluble pd-l1 (spd-l1)
membrane pd-l1 (mpd-l1)
non-small cell lung cancer (nsclc)
url https://doi.org/10.2478/fco-2023-0036
work_keys_str_mv AT tathangba changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT phamnhungthikim changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT nguyendungtien changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT trantienviet changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT trancuongtan changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT congluongthuc changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT vuhoanngoc changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT lehienthidieu changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer
AT daobangngoc changesinsolublepdl1levelsinpatientswithadvancednonsmallcelllungcancer